Skip to main content
Symptom
dx.
Menu
Clinical Reference
Approaches
I have a symptom
Management
I know the diagnosis
Orthopedic Injuries
Fractures & dislocations
Calculators
Clinical calculators
Practical Skills
ECG
Interpretation guide
POCUS
Bedside ultrasound
Procedures
Step-by-step guides
Resuscitation
ACLS / PALS / NRP
Learn
Blog
Articles & updates
Deep Dive
In-depth clinical reviews
About
Our mission
Symptom
dx.
Clinical Reference
Approaches
I have a symptom
Management
I know the diagnosis
Orthopedic Injuries
Fractures & dislocations
Calculators
Clinical calculators
Practical Skills
ECG
Interpretation guide
POCUS
Bedside ultrasound
Procedures
Step-by-step guides
Resuscitation
ACLS / PALS / NRP
Learn
Blog
Articles & updates
Deep Dive
In-depth clinical reviews
About
Our mission
Get Started
Menu
Clinical Reference
Approaches
I have a symptom
Management
I know the diagnosis
Orthopedic Injuries
Fractures & dislocations
Calculators
Clinical calculators
Practical Skills
ECG
Interpretation guide
POCUS
Bedside ultrasound
Procedures
Step-by-step guides
Resuscitation
ACLS / PALS / NRP
Learn
Blog
Articles & updates
Deep Dive
In-depth clinical reviews
About
Our mission
Loading...
Mitral Regurgitation (Acute)
Cardiovascular Presentations
Abdominal aortic aneurysm
Acute coronary syndrome (NSTEMI)
Acute coronary syndrome (STEMI)
Acute decompensated heart failure
Acute limb ischemia
Acute mesenteric ischemia
Aortic dissection
Aortic stenosis
Atrial fibrillation and flutter
Bradyarrhythmia and heart block
Cardiac arrest
Deep vein thrombosis
Myocarditis
Pericarditis
Pulmonary embolism
Stable angina
Superficial thrombophlebitis
Superior vena cava syndrome
Supraventricular tachycardia
Syncope (cardiogenic)
Unstable angina
Ventricular tachycardia
Respiratory Presentations
Acute bronchitis
Acute respiratory failure
Aspiration pneumonia
Asthma exacerbation
Bronchiolitis
Community-acquired pneumonia
COVID-19 pneumonia
COPD exacerbation
Croup
Croup (laryngotracheobronchitis)
Epiglottitis
Hemothorax
Hospital-acquired pneumonia
Pleural effusion
Pneumothorax (traumatic)
Pulmonary contusion
Spontaneous pneumothorax
Neurological Presentations
Bell's palsy
Benign paroxysmal positional vertigo
Brain abscess
Cauda equina syndrome
Cervical radiculopathy
Concussion (mild traumatic brain injury)
Encephalitis
Guillain-Barré syndrome
Hemorrhagic stroke (intracerebral)
Ischemic stroke
Lumbar radiculopathy
Malignant spinal cord compression
Migraine
Peripheral neuropathy (acute)
Retropharyngeal abscess
Schizophrenia (acute exacerbation)
Seizure (breakthrough:known epilepsy)
Seizure (first-time)
Spinal cord injury
Status epilepticus
Subarachnoid hemorrhage
Tension headache
Transient ischemic attack
Traumatic brain injury (moderate-severe)
Vestibular neuritis
Viral meningitis
Gastrointestinal Presentations
Acute appendicitis
Acute cholecystitis
Acute diverticulitis
Acute pancreatitis
Anal fissure
Choledocholithiasis and cholangitis
Clostridioides difficile colitis
Gastritis
Gastroenteritis (viral and bacterial)
Gastroesophageal reflux disease
Incarcerated or strangulated hernia
Inflammatory bowel disease flare
Large bowel obstruction
Lower GI hemorrhage
Peptic ulcer disease
Perforated viscus
Small bowel obstruction
Upper GI hemorrhage
Genitourinary and Reproductive Presentations
Acute prostatitis
Acute urinary retention
Ectopic pregnancy
Epididymitis
Orchitis
Ovarian torsion
Paraphimosis
Pelvic inflammatory disease
Priapism
Pyelonephritis
Renal laceration
Ruptured ovarian cyst
Testicular torsion
Tubo-ovarian abscess
Urinary tract infection (uncomplicated)
Urolithiasis (renal colic)
Vaginal bleeding (non-pregnant)
Infectious Disease Presentations
Acute sinusitis
Acute tonsillitis
Acute upper respiratory infection
Animal bite
Bacterial meningitis
Cellulitis
Conjunctivitis (bacterial)
Dental abscess
Endocarditis
Febrile neutropenia
Fournier gangrene
Hand-foot-mouth disease
Hepatitis (acute)
Herpes zoster
HIV-related illness
Human bite
Impetigo
Infected diabetic foot ulcer
Infectious mononucleosis
Influenza
Necrotizing fasciitis
Osteomyelitis
Otitis externa
Parasitic infection
Periorbital cellulitis
Peritonsillar abscess
Scabies
Sepsis
Septic arthritis
Spontaneous bacterial peritonitis
Tick-borne illness (Lyme disease)
Tinea infection
Tuberculosis
Viral exanthem
Wound infection
Trauma Presentations
Achilles tendon rupture
ACL and mceniscus tear
Ankle fracture
Ankle sprain
Burn
Calcaneus fracture
Cervical spine fracture
Clavicle fracture
Dental avulsion
Distal radius fracture
Drowning
Elbow fracture and dislocation
Electrical injury
Facial bone fracture
Facial laceration
Femur fracture
Fingertip amputation
Forearm fracture (radius and ulna)
Frostbite
Hand:finger laceration
Heat exhaustion
Heat stroke
Hip fracture
Humeral shaft fracture
Knee dislocation
Knee sprain
Lightning injury
Mandible fracture
Metacarpal fracture
Metatarsal fracture
Muscle strain
Nasal fracture
Non-accidental trauma
Orbital fracture
Patella fracture
Phalanx fracture (finger)
Proximal humerus fracture
Pulmonary contusion
Rib fracture
Rotator cuff tear (acute traumatic)
Scalp laceration
Scaphoid fracture
Shoulder dislocation
Skull fracture
Splenic laceration
Sternal fracture
Supracondylar pediatric fracture
Tendon laceration (hand:wrist)
Thoracic and lumbar spine fracture
Tibia:fibula fracture
Tibial plateau fracture
Toe fracture
Traumatic epistaxis
Traumatic hyphema
Toxicologic Presentations
Acetaminophen toxicity
Alcohol intoxication
Alcohol withdrawal
Anticholinergic toxicity
Anticoagulant overdose
Benzodiazepine overdose
Benzodiazepine:sedative overdose
Beta-blocker and calcium channel blocker toxicity
Carbon monoxide poisoning
Caustic ingestion
Digoxin toxicity
Drug eruption
Foreign body ingestion
Opioid intoxication
Opioid overdose
Opioid withdrawal
Organophosphate
Salicylate toxicity
Serotonin syndrome
Stimulant intoxication (cocaine, methamphetamine)
Tricyclic antidepressant overdose
Psychiatric Presentations
Acute anxiety
Acute psychosis
Agitation:behavioral emergency
Bipolar disorder
Conversion disorder
Major depressive episode
Neuroleptic malignant syndrome
Suicidal ideation and attempt
Musculoskeletal and Rheumatologic Presentations
Acute low back pain (mechanical)
Bursitis
Cervical radiculopathy
Costochondritis
Gout (acute)
Lumbar radiculopathy
Pseudogout
Tendinitis
Dermatology Presentations
Acute eczema (Eczema acute flare)
Allergic contact dermatitis
Erythema multiforme
Henoch-Schönlein purpura
Pressure injury
Psoriasis (acute flare)
Stevens-Johnson syndrome
Toxic epidermal necrolysis
Urticaria (acute)
Environmental and Exposure Presentations
Envenomation (snake, spider, insect)
High-altitude illness
Hypothermia
Hematologic and Oncologic Presentations
Acute chest syndrome
Coagulopathy
Hyperviscosity syndrome
Sickle cell crisis (vaso-occlusive)
Symptomatic anemia
Thrombocytopenia (severe)
Tumor lysis syndrome
Pediatric-Specific Presentations
Bronchiolitis
Croup
Emergency delivery
Febrile seizure
Kawasaki disease
Neonatal jaundice
Neonatal sepsis
Nursemaid's elbow
Pediatric fever 0 to 28 days
Pediatric fever 29 to 60 days
Pediatric fever 61 to 90 days
Pyloric stenosis
Slipped capital femoral epiphysis
Intussusception
Endocrine and Metabolic Presentations
Adrenal crisis
Diabetic ketoacidosis
Hypercalcemia
Hyperosmolar hyperglycemic state
Hypertensive emergency
Hypertensive urgency
Hypoglycemia
Myasthenia gravis crisis
Myxedema coma
Severe hyperkalemia
Severe hyponatremia
Thyroid storm
ENT and Maxillofacial Presentations
Acute laryngitis
Acute otitis media
Acute pharyngitis
Cerumen impaction
Epistaxis (anterior)
Nasal foreign body
Otitis externa
Tympanic membrane perforation
Ophthalmologic Presentations
Acute angle-closure glaucoma
Central retinal artery occlusion
Chemical eye injury
Corneal abrasion
Corneal ulcer
Globe rupture
Ocular foreign body
Orbital cellulitis
Retinal detachment
Obstetric Presentations
Hyperemesis gravidarum
Painful vaginal bleeding in pregnancy
Placenta previa
Placental abruption
Preeclampsia:eclampsia
Preterm labor
Threatened:inevitable:incomplete abortion
Systemic and Miscellaneous Presentations
Anaphylaxis
Angioedema
Cannabis-induced hyperemesis
Mitral Regurgitation (Acute)
POCUS
Procedures
Calculators
Resuscitation
ECG Guide
Back
Clinical Assessment Checklist
Browse categories and answer follow-up questions to refine your symptom profile.
Approach to the Critical Patient
Immediate priorities
Airway and ventilation threats
▶
Flash pulmonary edema with respiratory failure
▶
SpO2 < 90% on maximal non-invasive support
Increasing work of breathing with fatigue
Oxygenation failure
▶
PaO2 < 60 mmHg on supplemental oxygen
Bilateral crackles with frothy sputum
If intubation required, RSI with hemodynamic-safe agents
▶
Ketamine or etomidate for induction
Ventilation increases afterload and may worsen cardiac output
Circulation and shock threats
▶
Cardiogenic shock criteria
▶
SBP < 90 mmHg or MAP < 65 mmHg
Lactate >= 2 mmol/l with end-organ signs
Cool extremities with oliguria and altered mental status
Acute hemodynamic deterioration post-MI
▶
New hypotension with hyperdynamic LV on echo suggests papillary muscle rupture
Typically 3-5 days post-transmural infarction
If cardiogenic shock, initiate simultaneous afterload reduction and inotropic support
▶
Dobutamine plus nitroprusside bridge to surgical intervention
IABP as bridge to surgery when pharmacologic support insufficient
Monitoring and targets
Hemodynamic monitoring
▶
Arterial line for continuous blood pressure and titration
▶
Narrow pulse pressure as early shock marker
Vasopressor titration target MAP >= 65 mmHg
Continuous pulse oximetry
▶
SpO2 target 92-96%
Rapid deterioration mandates escalation
Pulmonary artery catheter consideration in refractory shock
▶
Large V waves on PCWP tracing pathognomonic for severe MR
Differentiates VSD (step-up in O2 saturation) from MR
Guides hemodynamic management in complex shock
Escalation triggers and consults
Surgical and specialist consults
▶
Cardiac surgery consultation immediately for all acute severe MR
▶
Papillary muscle rupture is a surgical emergency
Hospital mortality approaches 80% without surgical correction
Cardiology consultation for hemodynamic management and echo guidance
▶
TEE if TTE non-diagnostic
Coronary angiography if ischemic etiology suspected
Critical care or cardiac ICU for all cardiogenic shock presentations
▶
IABP insertion capability
Impella or ECMO consideration in refractory shock
History
Presentation pattern
Core presenting syndrome
▶
Acute dyspnea onset
▶
Minutes to hours onset distinguishes acute from chronic
Orthopnea and inability to lie flat
Pink frothy sputum in severe pulmonary edema
Chest pain context
▶
Inferior STEMI association with posteromedial papillary muscle rupture
Pain onset preceding acute dyspnea by 3-5 days
Absence of prior heart failure symptoms
▶
No chronic exertional dyspnea
No prior lower extremity edema
Key distinguishing feature from decompensated chronic MR
Etiologic context
Ischemic etiology clues
▶
Recent MI or ACS presentation
▶
Inferior or lateral STEMI highest risk
Single-vessel posteromedial papillary muscle supply increases vulnerability
Timing relative to MI
▶
3-5 days post-transmural infarction peak risk for rupture
Early hours post-MI suggest ischemia without rupture
Infectious etiology clues
▶
Fevers, rigors, night sweats
▶
Preceding dental procedures or oral manipulations
Intravenous drug use history
New skin lesions or embolic phenomena
Prosthetic valve history
▶
Recent bacteremia
Prior endocarditis
Structural or myxomatous etiology
▶
Known mitral valve prolapse
▶
Myxomatous valve disease most common cause of acute severe MR overall
May have sudden chordal rupture without precipitating event
Connective tissue disorder
▶
Marfan syndrome
Ehlers-Danlos syndrome
Risk factors
Papillary muscle rupture risk
▶
Delayed MI presentation
▶
Older age
Female sex
Inferior or lateral STEMI
Comorbidities increasing risk
▶
Chronic kidney disease
Prior heart failure
Single-vessel coronary disease with poor collaterals
Endocarditis risk
▶
Intravenous drug use
▶
Staphylococcus aureus predominant pathogen
Prosthetic valve
▶
Early vs late prosthetic valve endocarditis distinction
Structural vulnerability
▶
Indwelling vascular catheters
Immunosuppression
Poor oral hygiene
Other structural causes
▶
Takotsubo cardiomyopathy
▶
Emotional or physical stress trigger
Predominantly postmenopausal women
Blunt chest trauma
▶
Mechanism review
Steering wheel or direct precordial impact
Physical Exam
Vitals and general appearance
Hemodynamic profile
▶
Tachycardia
▶
Compensatory response to reduced forward output
Rate > 120 per minute associated with worse outcomes
Hypotension
▶
Narrow pulse pressure distinguishes from aortic regurgitation
SBP < 90 mmHg defines shock threshold
Tachypnea
▶
Rate >= 30 per minute as severity marker
Accessory muscle use and inability to speak in full sentences
Hypoxia
▶
SpO2 < 90% on room air
Rapid deterioration without oxygen support
Cardiac exam
Murmur characteristics
▶
Murmur may be soft, decrescendo, or entirely absent
▶
Rapid LA-LV pressure equalization reduces gradient
Soft murmur does NOT exclude severe MR
Classic pitfall: severity inversely related to murmur loudness in acute setting
S3 gallop or early diastolic rumble
▶
May be the only abnormal auscultatory finding
Indicates elevated filling pressures
Apical impulse
▶
Non-displaced in acute MR
LV not yet dilated unlike chronic MR
Additional cardiac findings
▶
JVD elevation
▶
Biventricular failure component
Right heart strain from acute pulmonary hypertension
S4 gallop in ischemic MR
▶
Stiff non-compliant ischemic LV
Loss of atrial contribution noted
Pulmonary exam
Respiratory findings
▶
Bilateral crackles
▶
Diffuse in acute pulmonary edema
Cephalization on exam and imaging
Wheezing
▶
Pulmonary edema-induced bronchospasm
Cardiac asthma pattern
Pink frothy sputum
▶
Severe flash pulmonary edema
Immediate escalation trigger
Endocarditis stigmata
Peripheral signs of infective endocarditis
▶
Splinter hemorrhages
▶
Non-blanching subungual linear lesions
Janeway lesions
▶
Painless erythematous macules on palms and soles
Osler nodes
▶
Painful nodules on fingertips
Immune complex deposition mechanism
Conjunctival petechiae
▶
Roth spots on fundoscopy if available
New focal neurologic deficit
▶
Embolic stroke complication
PITFALLS
Diagnostic pitfalls in acute MR
▶
Absent or soft murmur misinterpreted as low probability
▶
Classic error: assumes no MR if murmur quiet
Degree of regurgitation not proportional to murmur volume
Echo underestimation of severity
▶
Color Doppler jet may appear small and eccentric
Systolic flow reversal in pulmonary veins is confirmatory
Normal cardiac silhouette on CXR
▶
Cardiomegaly absent in acute MR (no time for remodeling)
Pulmonary edema on CXR with normal heart size should raise suspicion
Differential Diagnosis
Life-threatening mimics
Post-MI mechanical complications
▶
Ventricular septal rupture
▶
ICD-10 I23.2
Similar timing 3-5 days post-MI
New holosystolic murmur at left sternal border
Step-up in O2 saturation at RV level on PA catheter
Free wall rupture with tamponade
▶
ICD-10 I23.3
PEA arrest pattern
Echo shows hemopericardium
Papillary muscle rupture (complete)
▶
ICD-10 I23.5
Most catastrophic form
Flail leaflet on echo
Cardiogenic shock from other causes
▶
Acute decompensated heart failure
▶
ICD-10 I50.9
Dilated LV with reduced EF on echo
No new murmur or structural defect
Massive pulmonary embolism
▶
ICD-10 I26.0
RV dilation and McConnell sign on echo
Clear lung fields on examination
Valvular mimics
Acute aortic regurgitation
▶
ICD-10 I06.1 or I35.1
▶
Wide pulse pressure distinguishes from acute MR
Diastolic murmur at left sternal border
Aortic dissection or endocarditis etiology
Dynamic LVOT obstruction
▶
ICD-10 I42.1 for HOCM
▶
Systolic murmur worsened by vasopressors
Systolic anterior motion (SAM) on echo
Takotsubo with LVOT obstruction pattern
Shock mimics
Cardiac tamponade
▶
ICD-10 I31.9
▶
Hypotension with JVD and muffled heart sounds
Echo shows effusion with RV collapse
Pulsus paradoxus > 10 mmHg
Septic shock with cardiac depression
▶
ICD-10 A41.9
▶
Fever, elevated lactate, distributive shock
Endocarditis overlap must be excluded
Blood cultures and echo essential
Laboratory Tests
Cardiac biomarkers
Troponin
▶
Elevated in ischemic papillary muscle rupture
▶
High sensitivity troponin at 0 and 1-2 hours
Serial rise confirms acute myocardial necrosis
Elevated in myocarditis or stress cardiomyopathy
▶
Pattern may help guide etiology
Limitations: non-specific; also elevated in PE and sepsis
BNP and NT-proBNP
▶
Elevated confirming acute heart failure
▶
BNP > 100 pg/ml (100 ng/l) supports diagnosis
NT-proBNP > 300 pg/ml threshold
May not be markedly elevated very early in acute onset
▶
Normal value does not exclude diagnosis
Trend more useful than single value
Metabolic and organ function
Lactate
▶
>= 2 mmol/l indicates tissue hypoperfusion
▶
Cardiogenic shock marker
Serial measurement guides resuscitation response
Failure to clear lactate at 2 hours suggests inadequate support
Complete metabolic panel
▶
Renal function
▶
Creatinine elevation in cardiorenal syndrome
eGFR influences drug dosing for IV contrast and medications
Electrolytes
▶
Hypokalemia and hypomagnesemia from diuresis
Hyponatremia as poor prognosis marker
Hepatic function
▶
Elevated AST and ALT from hepatic congestion
Elevated bilirubin in right heart failure component
Infection workup
Blood cultures
▶
Minimum 2 sets from separate sites before antibiotics
▶
Essential if endocarditis suspected
Staphylococcus aureus most common organism in IVDU
Timing critical
▶
Do not delay antibiotics more than 1 hour in hemodynamic instability
Document culture time relative to antibiotic administration
Complete blood count
▶
Leukocytosis supporting infectious etiology
▶
Bandemia as additional severity marker
Anemia
▶
Hemolysis in prosthetic valve involvement
Chronic blood loss in endocarditis
Pre-operative and procedural labs
Coagulation studies
▶
PT INR and aPTT for surgical planning
▶
Anticoagulation reversal if urgent surgery
Heparin bridging considerations
Arterial blood gas
▶
PaO2 and PaCO2 assessment
▶
Degree of hypoxemia quantification
Respiratory acidosis indicating ventilatory failure
pH and bicarbonate
▶
Metabolic acidosis from low output state
Lactic acidosis correlation
Type and screen
▶
Pre-operative preparation for cardiac surgery
▶
Crossmatch for anticipated blood product use
Diagnostic Tests
Scoring Systems
IREMMI clinical classification of acute MR severity
▶
Type 1: Cardiogenic shock
▶
MAP < 90 mmHg
Elevated lactate
Requires vasoactive drugs or mechanical circulatory support
Type 2: Refractory pulmonary edema
▶
MAP > 90 mmHg
Low cardiac output
Diuretic-refractory
Type 3: Intermittent pulmonary edema
▶
MAP > 90 mmHg
Responds partially to diuretics
Type 4: Mild to moderate heart failure
▶
Oral diuretic responsive
Lower surgical urgency tier
Modified Duke Criteria for infective endocarditis
▶
Major criteria
▶
Positive blood cultures with typical organism
Evidence of endocardial involvement on echo
Minor criteria
▶
Predisposing condition
Fever >= 38 C
Vascular phenomena
Immunologic phenomena
Definite: 2 major, or 1 major plus 3 minor, or 5 minor criteria
MRI
Cardiac MRI role in acute MR
▶
Limited acute utility
▶
Not indicated in hemodynamically unstable patient
Availability and time constraints preclude use in emergent setting
Subacute and problem-solving indications
▶
Precise regurgitant volume quantification
Myocardial viability assessment when ischemic etiology uncertain
Myocarditis differentiation from ischemic papillary muscle dysfunction
Contraindications
▶
Hemodynamic instability
Non-MRI compatible devices
Active mechanical circulatory support devices
CT
CT chest indications
▶
Coronary CT angiography if ischemic etiology uncertain and patient stable
▶
Not first-line: invasive coronary angiography preferred when revascularization likely
Alternative when cath lab not immediately available
CT chest for aortic dissection exclusion
▶
Acute AR and MR can both complicate Type A dissection
Sensitivity and specificity approaching 100% for aortic dissection
ACEP Level B recommendation for CTA in aortic syndrome evaluation
CT pulmonary angiogram if PE differential remains
▶
RV strain on CT supports PE diagnosis
Integrate with echo findings
CXR findings in acute MR
▶
Pulmonary edema pattern
▶
Bilateral alveolar infiltrates
Kerley B lines
Cephalization of pulmonary vasculature
Normal cardiac silhouette
▶
Distinguishes from chronic MR with cardiomegaly
Key diagnostic clue when combined with acute pulmonary edema
Ultrasound
Transthoracic echocardiography
▶
First-line cardiac imaging
▶
Mechanism identification: flail leaflet, papillary muscle rupture, vegetations
LV function assessment: hyperdynamic LV with low forward output
RV function and pulmonary artery pressure estimation
Color Doppler limitations
▶
Jet may appear deceptively small due to jet eccentricity and wall impingement
Coanda effect with eccentric jets causes MR severity underestimation
Systolic flow reversal in pulmonary veins is highly specific for severe MR
Quantitative parameters
▶
Vena contracta width > 7 mm supports severe MR
EROA (effective regurgitant orifice area) > 0.4 cm2 for severe MR
Transesophageal echocardiography
▶
Indications
▶
TTE non-diagnostic or equivocal
Better anatomic definition of valve apparatus
Surgical planning for repair vs replacement decision
Superior sensitivity for
▶
Papillary muscle rupture characterization
Vegetation detection and size measurement
Annular abscess and perivalvular extension
Leaflet perforation in endocarditis
Limitation: requires sedation and esophageal intubation
Point-of-care ultrasound
▶
Rapid bedside assessment
▶
B-lines indicating pulmonary edema (multiple bilateral zones)
Hyperdynamic LV with visual estimation of function
Pericardial effusion exclusion
IVC assessment
▶
Collapsing IVC with tachycardia suggests low preload state
Plethoric non-collapsing IVC in biventricular failure
Disposition
ICU and surgical indications
Cardiac ICU or monitored care mandatory
▶
All acute severe MR requires intensive monitoring
▶
Hemodynamic instability risk is high and unpredictable
Rapid deterioration to cardiogenic shock common
Cardiogenic shock mandate
▶
Vasopressor or mechanical circulatory support requirement
Lactate >= 2 mmol/l with hemodynamic compromise
Immediate surgical referral
▶
Papillary muscle rupture
▶
Emergent surgery reduces in-hospital mortality
Bridge with IABP or Impella if hemodynamically unstable
Hospital mortality 10-40% with surgery vs approaching 80% without
Severe chordal rupture with refractory heart failure
▶
Urgent rather than emergent surgery if hemodynamically stable
Endocarditis with severe MR
▶
Surgery within 24-72 hours in heart failure or septic emboli
Valve repair preferred when feasible
Transfer criteria
Transfer to cardiac surgery center
▶
If current facility lacks cardiac surgery capability
▶
Stabilize with afterload reduction and IABP before transfer
Do not delay transfer once diagnosis confirmed
Hemodynamic stabilization priority before transport
▶
Arterial line placed
Inotropic and vasodilator infusions running
Transport team with cardiac capability
Discharge and follow-up
Copy
Discharge criteria for non-surgical management
▶
Type 4 (mild to moderate HF) with complete symptom resolution
▶
SpO2 > 92% on room air
Ambulating without dyspnea
Clear follow-up plan established
▶
Cardiology within 1-2 weeks
Definitive surgical planning discussion completed
Outpatient follow-up requirements
▶
Cardiology and cardiac surgery evaluation
Serial echo for monitoring progression
Anticoagulation plan if AF present
Treatment
Airway and oxygen support
Supplemental oxygen
▶
Nasal cannula or face mask titration
▶
SpO2 target 92-96%
Avoid hyperoxia
High-flow nasal cannula for moderate hypoxemia
▶
Flow 30-60 L/min
FiO2 titration to target
Non-invasive positive pressure ventilation
▶
CPAP 5-10 cmH2O for flash pulmonary edema
BiPAP if hypercapnic component
Avoid if hemodynamic instability or altered consciousness
Afterload reduction
Sodium nitroprusside
▶
First-line vasodilator in normotensive acute MR
▶
Reduces LV afterload and regurgitant fraction
Increases forward cardiac output
Dosing
▶
Initial 0.3-0.5 mcg/kg/min IV infusion
Titrate every 5-10 minutes
Target SBP 90-110 mmHg or clinical improvement
Maximum 10 mcg/kg/min
Monitoring
▶
Arterial line mandatory
Cyanide toxicity risk with prolonged use > 72 hours or renal failure
Methemoglobin monitoring in prolonged infusions
Nitroglycerin
▶
Alternative when nitroprusside unavailable
▶
IV infusion 10-20 mcg/min initial
Titrate by 10-20 mcg/min every 5 minutes
Maximum 400 mcg/min
Less potent arterial vasodilator than nitroprusside
▶
Predominantly venodilator at lower doses
Tachyphylaxis within 24 hours
Inotropic support
Dobutamine
▶
Cardiogenic shock with reduced forward output
▶
Combined with afterload reduction for hemodynamic optimization
Dosing
▶
Initial 2-5 mcg/kg/min IV infusion
Titrate by 2 mcg/kg/min every 10-15 minutes
Maximum 20 mcg/kg/min
Target MAP >= 65 mmHg with improved urine output
Monitoring
▶
Tachycardia and arrhythmia risk
Wean as hemodynamics permit and definitive treatment instituted
Milrinone
▶
Alternative inotrope with vasodilatory properties
▶
Loading dose 50 mcg/kg IV over 10 minutes
Maintenance 0.375-0.75 mcg/kg/min
Reduce dose in renal impairment
Advantage in beta-blocker-treated patients
▶
Mechanism bypasses beta receptor
Diuresis
Furosemide IV
▶
Pulmonary congestion management
▶
Initial 0.5-1 mg/kg IV bolus (typically 40-80 mg IV)
If chronic diuretic use, give 1-1.5 times oral dose IV
Target urine output 0.5-1 ml/kg/hr
High-dose or continuous infusion if bolus insufficient
▶
Infusion 5-40 mg/hr
Electrolyte replacement essential
Medications to avoid
▶
Pure vasoconstrictors (phenylephrine, norepinephrine as sole agent)
▶
Increase LV afterload and worsen regurgitant fraction
Use only when vasodilatory shock coexists and MAP < 50 mmHg
Beta-blockers in acute decompensated state
▶
Reduce compensatory tachycardia and may worsen cardiac output
Not indicated in acute phase
Mechanical circulatory support
Intra-aortic balloon pump
▶
Bridge to surgery in hemodynamically unstable patients
▶
Reduces LV afterload in diastole
Increases diastolic coronary perfusion
Contraindicated in moderate-severe aortic regurgitation
Timing
▶
Insert before transfer if patient deteriorating
Class IIa recommendation in cardiogenic shock from mechanical MI complications
Impella ventricular assist device
▶
Refractory cardiogenic shock
▶
Impella CP (3.5 L/min) or Impella 5.0 (5 L/min) based on severity
Unloads LV and increases forward cardiac output
Contraindications
▶
Severe aortic stenosis or regurgitation
LV thrombus
Mechanical aortic valve
Endocarditis-specific treatment
Empiric antibiotic therapy
▶
IVDU-associated or community-acquired
▶
Vancomycin IV 25-30 mg/kg loading dose
Target AUC 400-600 mg-h/L or trough 15-20 mcg/ml
Plus gentamicin 1 mg/kg IV every 8 hours if synergy indicated
Prosthetic valve endocarditis
▶
Vancomycin plus gentamicin plus rifampin 300 mg PO/IV every 8 hours
Duration minimum 6 weeks for prosthetic valve
Tailor to culture results when available
▶
Penicillin G or ampicillin for susceptible streptococcal species
Anti-staphylococcal penicillin (oxacillin) for MSSA if not MRSA
Special Populations
Pregnancy
Pregnancy-specific considerations
▶
Physiologic changes affecting presentation
▶
Increased blood volume 40-50% raises baseline preload
Reduced SVR may initially buffer MR hemodynamic impact
Peripartum state associated with chordal rupture and Takotsubo MR
Imaging approach
▶
TTE preferred; no radiation risk
CXR with abdominal shielding when clinical necessity
Avoid CT unless aortic dissection excluded urgently
Medication safety
▶
Nitroprusside: use with caution; potential fetal cyanide toxicity with prolonged use
Nitroglycerin: generally preferred vasodilator in pregnancy
Furosemide: crosses placenta but used when pulmonary edema life-threatening
Avoid ACE inhibitors and ARBs in second and third trimesters
Delivery planning
▶
Multidisciplinary team: cardiology, obstetrics, cardiac surgery
Mode of delivery individualized based on hemodynamic stability
Vaginal delivery preferred if stable to avoid surgical anesthesia risks
IABP and mechanical support may be considered as bridge
Geriatric
Older adult features
▶
Higher prevalence of papillary muscle rupture from MI
▶
Older women at highest risk with inferior STEMI
Delayed presentation increases post-MI complication risk
Atypical presentation
▶
Delirium or confusion as primary symptom
Weakness and reduced activity rather than dyspnea
Medication adjustments
▶
Renal dosing of diuretics and antibiotics
Nitroprusside: increased cyanide toxicity risk in elderly with renal impairment
Gentamicin: reduced dosing frequency, extended interval monitoring
Surgical risk assessment
▶
Frailty scoring impacts operative mortality estimates
STS score essential for risk stratification
High surgical risk patients may be candidates for transcatheter MV interventions
Polypharmacy and drug interactions
▶
QT prolongation risk from multiple cardiac medications
Electrolyte monitoring with aggressive diuresis
Pediatrics
Pediatric acute MR causes
▶
Infective endocarditis
▶
Congenital heart disease as predominant risk factor
IVDU in adolescents
Acute rheumatic fever
▶
Carditis with MR
Preceding Group A streptococcal pharyngitis
Jones criteria for diagnosis
Kawasaki disease complication
▶
Coronary aneurysm with papillary muscle ischemia
Congenital mitral valve anomalies
▶
Cleft mitral valve
Parachute mitral valve
Pediatric management differences
▶
Weight-based dosing
▶
Furosemide 1-2 mg/kg IV (max 6 mg/kg per dose)
Milrinone 0.25-0.75 mcg/kg/min infusion
Dobutamine 2-20 mcg/kg/min
Antibiotic therapy for endocarditis
▶
Vancomycin 15 mg/kg IV every 6 hours (max 60 mg/kg/day)
Gentamicin 1-1.5 mg/kg IV every 8 hours with level monitoring
Surgical referral
▶
Pediatric cardiac surgery center
Valve repair strongly preferred over replacement in children
Prosthetic valve in children requires lifelong anticoagulation
Background
Epidemiology
Incidence and etiology distribution
▶
Chordal rupture (myxomatous disease)
▶
Most common cause of acute severe MR in developed countries
Estimated prevalence of myxomatous MVP 2-3% of general population
Annual risk of chordal rupture in MVP approximately 1-2% per year
Papillary muscle rupture post-MI
▶
0.05-0.26% of all MI patients
Higher incidence with inferior STEMI and incomplete revascularization
Incidence declining with early reperfusion therapy
Infective endocarditis
▶
Native valve endocarditis incidence 3-7 per 100,000 person-years
IVDU-associated endocarditis disproportionately affects mitral and aortic valves
Mortality data
▶
Papillary muscle rupture without surgery
▶
Hospital mortality approaching 80% at 30 days
Median survival 24 hours without intervention
Papillary muscle rupture with emergency surgery
▶
In-hospital mortality 10-40% depending on institutional experience
Long-term survival 40-50% at 5 years
Overall acute severe MR
▶
30-day mortality 20-25% with cardiogenic shock
Highest risk: delayed diagnosis, elderly, comorbidities
Pathophysiology
Acute hemodynamic mechanisms
▶
Volume overload on unprepared chambers
▶
Normal LV suddenly must eject into both aorta and low-resistance LA
LA and pulmonary venous pressures rise acutely
Pulmonary edema develops as LA compliance is overwhelmed
LV response
▶
Compensatory tachycardia increases cardiac output
LV ejection fraction appears supranormal (150-170%)
LV stroke volume partially directed backwards into LA
Normal LV size: no time for eccentric hypertrophy to develop
Contrast with chronic MR
▶
Chronic MR: dilated compliant LA buffers pressure rise
Chronic MR: eccentric LV hypertrophy compensates for volume overload
Acute MR: small non-compliant LA cannot buffer; immediate pressure rise
Etiologic mechanisms
▶
Papillary muscle rupture
▶
Posteromedial papillary muscle receives single blood supply from RCA or circumflex
Anterolateral papillary muscle has dual supply from LAD and circumflex
Partial rupture causes severe MR; complete rupture is universally fatal without surgery
Chordal rupture
▶
Myxomatous degeneration weakens chordae tendineae
Sudden chordal failure creates flail leaflet
Posterior leaflet more commonly affected (60-70%)
Endocarditis
▶
Bacterial vegetation destroys leaflet integrity
Leaflet perforation or avulsion causes acute regurgitation
Annular abscess can disrupt valve competence
Therapeutic Considerations
Surgical timing principles
▶
Emergency surgery
▶
Cardiogenic shock from papillary muscle rupture
Severe acute MR with refractory pulmonary edema
Delay increases mortality; every hour without surgery worsens prognosis
Urgent surgery (24-72 hours)
▶
Hemodynamically stable but severe MR with heart failure
Endocarditis with large vegetation and embolic risk
Surgical options
▶
Mitral valve repair preferred over replacement when feasible
Repair preserves subvalvular apparatus and LV function
Mechanical prosthesis requires lifelong anticoagulation
Bioprosthesis suitable for older patients avoiding anticoagulation
Medical bridge principles
▶
Goal is hemodynamic stabilization before definitive intervention
▶
Afterload reduction to decrease regurgitant fraction
Inotropic support when cardiac output compromised
Diuresis for pulmonary congestion
Medical therapy alone is palliative
▶
Not curative for structural causes
Reserved for prohibitive surgical risk cases
Transcatheter options
▶
MitraClip for prohibitive surgical risk patients
▶
Edge-to-edge repair technique
Less well-studied in acute severe MR than chronic degenerative MR
Emerging as bridge or definitive therapy in selected centers
Patient Discharge Instructions
copy discharge instructions
Copy
Acute mitral regurgitation follow-up care
▶
Attend all scheduled cardiology appointments
▶
Follow-up echocardiogram as instructed
Cardiac surgery consultation if not yet completed
Take all prescribed medications exactly as directed
▶
Do not stop heart medications without physician guidance
Blood pressure and heart medications are critical
Activity restrictions
▶
Avoid strenuous exertion until cleared by cardiologist
Gradual return to light activity as tolerated
No heavy lifting or vigorous exercise
Warning signs to return to the emergency room immediately
▶
Sudden severe shortness of breath
▶
Especially at rest or waking from sleep
Chest pain or pressure
Rapid or irregular heartbeat with dizziness
Fainting or near-fainting
Coughing up pink or blood-tinged sputum
Legs or ankles rapidly swelling
Confusion or difficulty thinking
Cool, pale, or mottled skin with weakness
Endocarditis prevention (if applicable)
▶
Antibiotic prophylaxis before dental procedures as directed
▶
Amoxicillin 2 g PO or ampicillin 2 g IV 30-60 minutes prior
Clindamycin 600 mg if penicillin allergic
Notify all healthcare providers of valve condition
Oral hygiene maintenance
▶
Twice daily brushing and flossing
Regular dental visits
Lifestyle guidance
▶
Low-sodium diet to reduce fluid retention
▶
Less than 2 g sodium daily
Fluid intake as directed by cardiologist
Daily weight monitoring
▶
Return to ER if weight increases more than 2 kg in 24 hours or 3 kg in 72 hours
Avoid intravenous drug use
▶
If IVDU: harm reduction resources and addiction medicine referral
References
Guidelines and key sources
Major society guidelines
▶
AHA ACC 2021 guideline for management of valvular heart disease
▶
Class I recommendation for surgery in acute severe MR causing hemodynamic instability
Class IIa for urgent surgery in stable severe MR with heart failure
ESC EACTS 2021 guidelines on valvular heart disease
▶
Emergency surgery recommendation for hemodynamic instability from acute MR
AHA ACC 2013 STEMI guideline update
▶
Mechanical complications including papillary muscle rupture addressed
Landmark studies and evidence
▶
SHOCK trial and registry data
▶
Mechanical complications of MI including acute MR outcomes
Early revascularization survival benefit data
EVEREST II trial
▶
MitraClip vs surgical repair in degenerative MR
Surgical repair superior in patients with acceptable surgical risk
COAPT trial
▶
MitraClip in heart failure with functional MR
Different phenotype from acute degenerative MR
Coding standards
▶
ICD-10 I34.0: Nonrheumatic mitral valve regurgitation
ICD-10 I23.5: Rupture of papillary muscle as current complication after acute MI
ICD-10 I33.0: Acute and subacute infective endocarditis
ICD-10 I23.2: Ventricular septal defect as current complication after acute MI
SNOMED CT: Acute mitral regurgitation disorder concept
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.
← Management Protocols
Home
Management Protocols
Mitral Regurgitation (Acute)